FDA
-
-
-
-
-
-
-
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sess
-
-
-
-
-
-
-
Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes
-
-
-
-
-
-
-
Insulet receives FDA clearance for Omnipod 5 algorithm enhancements
-
-
-
-
-
-
-
Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency¹)
-
-
-
-
-
-
-
Is Trump 2.0 good or bad for healthcare stocks?
-
-
-
-
-
-
-
Insulet (PODD): Omnipod 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes
-
-
-
-
-
-
-
Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year
-
333,995 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


